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Genomics of human aggression: current state of genome-
wide studies and an automated systematic review tool
Veronika V. Odintsovaa,b,c,*, Peter J. Roetmand,e,*, Hill F. Ipa, René Poola,  
Camiel M. Van der Laana,f, Klodiana-Daphne Tonad,e,  
Robert R.J.M. Vermeirend,e and Dorret I. Boomsmaa     
There are substantial differences, or variation, between 
humans in aggression, with its molecular genetic basis 
mostly unknown. This review summarizes knowledge on 
the genetic contribution to variation in aggression with 
the following three foci: (1) a comprehensive overview 
of reviews on the genetics of human aggression, (2) a 
systematic review of genome-wide association studies 
(GWASs), and (3) an automated tool for the selection 
of literature based on supervised machine learning. 
The phenotype definition ‘aggression’ (or ‘aggressive 
behaviour’, or ‘aggression-related traits’) included anger, 
antisocial behaviour, conduct disorder, and oppositional 
defiant disorder. The literature search was performed 
in multiple databases, manually and using a novel 
automated selection tool, resulting in 18 reviews and 17 
GWASs of aggression. Heritability estimates of aggression 
in children and adults are around 50%, with relatively 
small fluctuations around this estimate. In 17 GWASs, 
817 variants were reported as suggestive (P ≤ 1.0E−05), 
including 10 significant associations (P ≤ 5.0E−08). Nominal 
associations (P ≤ 1E−05) were found in gene-based tests 
for genes involved in immune, endocrine, and nervous 
systems. Associations were not replicated across GWASs. 
A complete list of variants and their position in genes 
and chromosomes are available online. The automated 
literature search tool produced literature not found by 
regular search strategies. Aggression in humans is 
heritable, but its genetic basis remains to be uncovered. 
No sufficiently large GWASs have been carried out yet. 
With increases in sample size, we expect aggression 
to behave like other complex human traits for which 
GWAS has been successful. Psychiatr Genet 29:170–190 
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Introduction
Aggression is a common type of human behaviour 
(Tuvblad and Baker, 2011) and is considered a character-
istic that is shared by all humans (Veroude et al., 2016). 
The propensity for aggression, however, varies consid-
erably between individuals. This article addresses the 
question to what extent the variation that is seen for 
aggression has a genetic cause. Broadly, aggression can 
be defined as a behaviour that intends to cause physi-
cal or emotional harm to others (Anderson and Bushman, 
2002). High levels of aggression are also seen in individ-
uals with severe mental disorders (e.g., autism, bipolar 
disorder, and schizophrenia) as well as in patients with 
(rare) Mendelian disorders (Zhang-James and Faraone, 
2016). Because of the large impact of aggression on the 
affected individual, their families, their environment, and 
society as a whole, there is a substantial interest in stud-
ying aggression from a wide range of disciplines. In this 
context, one goal is to unravel the aetiology of aggression 
by identifying environmental exposures and biomarkers, 
including genetic factors, epigenetic marks, and metab-
olites, that could function as predictors of (excessive) 
aggression (Boomsma et al., 2015).
Research often focuses on the pathological aspects of 
aggressive behaviour, while aggression does not solely 
have negative consequences or outcomes. Under cer-
tain circumstances, aggressive behaviour is beneficial 
to individuals, for example when competing for limited 
resources, like food or mates (Lindenfors and Tullberg, 
2011), or achieving social dominance (Hawley et al., 
2007). Aggression can further be a powerful deterrent 
against aggressive behaviour from others. Because both 
high and low levels of aggression can be detrimental 
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to survival and procreation, it has been postulated that 
aggression is under stabilizing selection, implying that 
variation in aggression should show significant herit-
ability. Substantial heritability estimates have indeed 
been reported in animals (Anholt and Mackay, 2012) and 
humans, as reviewed below.
Benefits of aggressive acts depend on the type of aggres-
sion, its success, environmental circumstances and also 
vary across cultures (Bukowski et al., 2011). For example, 
predatory goal-oriented aggression has been associated 
with social dominance in some instances (Dodge et al., 
1997; Hawley, 2003; Voulgaridou and Kokkinos, 2015), 
but this association seems to vary between groups that are 
more prosocial and groups that consist predominantly of 
individuals with disruptive behaviour problems (Wright et 
al., 1986). A decrease in social status can also result from 
aggression, in particular from reactive aggression, which is 
an uncontrolled type of aggression stemming from internal 
or external frustration. In reverse, after a conflict, proactive 
aggression is increased in the victorious party while the 
losing party is less likely to engage in another aggressive 
act (Polman et al., 2007; Penn et al., 2010). To differenti-
ate between different outcomes of aggression, researchers 
have distinguished aggression subtypes (e.g. reactive vs. 
proactive; overt vs. covert), developmental stages (child-
hood vs. adolescent onset), and comorbidities (e.g., with 
internalizing problems or with attention deficit hyperac-
tivity disorder (ADHD)). In summary, the outcomes and 
types of aggressive acts can differ greatly between persons 
and circumstances, and need not always be dysfunctional.
At the start of the 1990s, research on aggressive behaviour 
was given a new impulse by a seminal paper of Brunner 
et al. (1993), in which a Dutch pedigree was described 
where men exhibited impulsive aggression, arson, vio-
lence, and borderline mental retardation. The family 
appeared to have a rare point mutation in the structural 
gene for monoamine-oxidase-A (MAOA) – which codes 
for an enzyme that is involved in the oxidative deamina-
tion of neurotransmitters like dopamine, serotonin, and 
norepinephrine – resulting in a deficiency of the MAOA 
enzyme. A study, by Caspi et al. (2002), compared variants 
of the MAOA gene in children who experienced maltreat-
ment and showed that children with the variant resulting 
in lower levels of the MAOA enzyme were more likely to 
develop antisocial behaviour (ASB). Efforts to replicate 
the latter finding have been contradictory, either without 
replication (Haberstick et al., 2005; Young et al., 2006) or 
with replication (Foley et al., 2004; Kim-Cohen et al., 2006; 
Nilsson et al., 2018). Nevertheless, the studies of Brunner 
and Caspi stressed the importance of biological factors in 
the development of aggression and ASB. This instigated 
extensive efforts to study the genetic basis of aggression.
Enormous progress has been made with respect to tech-
nology in molecular biology and large-scale genotyping, 
as well as in the development of statistical methods for 
genetic association studies and polygenic scores for indi-
vidual risk assessment, once sufficiently large genetic-as-
sociation studies are available (Dudbridge, 2016). Costs 
for genotyping and sequencing of DNA, the epigenome 
and of RNA, and biomarker assessment, such as metab-
olomics, have steadily decreased, allowing for large stud-
ies, relating aggressive behaviour to genome, epigenome, 
transcriptome, and other biomarkers (Hagenbeek et al., 
2016). Progress also has been made in characterizing the 
exposome, which reflects the totality of a person’s envi-
ronmental exposures in space and time (Wild, 2005).
Genome-wide association studies (GWASs) provide a con-
ceptual framework to examine whether individual differ-
ences in aggression are associated with allelic differences 
in millions of single-nucleotide polymorphisms (SNPs) 
across the genome (Visscher et al., 2017). Because a GWAS 
targets the entire human genome, it enables a data-driven 
approach to identify loci of interest. This hypothesis-free 
approach could potentially help researchers to overcome 
limits imposed by multifactorial nature of a trait and 
incomplete understanding of its physiological basis.
Here, we synthesise knowledge deriving from studies on 
genetics of human aggression and variance in liability to 
aggression-related traits. Our review has three foci: (1) to 
give a comprehensive overview of reviews already done 
on genetics of human aggression, (2) to carry out a sys-
tematic review of GWAS studies on human aggression, 
and (3) to introduce an automated systematic review for 
the selection of relevant literature, based on supervised 
machine learning. For consistency, in this review, we will 
use the general term ‘aggression’ (or ‘aggressive behav-
iour’, or ‘aggression-related traits’) to refer to the termi-
nologies used by different authors (see Supplement S1, 
Supplemental digital content 1, http://links.lww.com/PG/
A223), including anger, hostility dimensions, parent-re-
ported child aggressive behaviour, physical aggression, 
ASB, violent offending, conduct disorders (CD), opposi-
tional defiant disorder (ODD), and antisocial personality 
disorder (ASPD).
Methods
To optimize detection of the relevant literature for our 
review, we incorporated two strategies:
1. A ‘traditional’ (manual) search strategy where search 
terms were used to extract the relevant articles from 
literature databases.
2. An automated screening with Automated Systematic 
Review Software (ASR) where relevant articles were 
detected via the utilization of machine learning algo-
rithms and a software development platform.
Traditional approach
Search strategy
Search terms were developed by the authors based on 
prior literature and discussions with an expert librarian 
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(J.W.S) from the LUMC. A literature search was per-
formed in PubMed, Embase, Web of Science, Cochrane 
library, PsychInfo and Academic Search Premier with a 
comprehensive list of general search terms and medical 
subject headings (Supplement S2, Supplemental digital 
content 2, http://links.lww.com/PG/A224). Searches were 
conducted separately for reviews/meta-analyses and 
GWA studies. Searches included literature without a spe-
cific time limit and were conducted in mid-April 2019.
Selection criteria
A selection was made from all titles and abstracts that 
were found in the databases using prespecified inclusion 
and exclusion criteria (Table 1). Articles were included if 
they (1) were written in English and (2) focused on human 
aggression. Studies were excluded if (1) they focused on 
animals, or (2) general terms linked to ‘aggression/violent 
etc.’ did not refer to a psychological/ psychiatric perspec-
tive but rather to characteristics of disease (e.g. aggres-
sive cancer), or (3) articles discussed only a single gene. 
Psychiatric disorders, which incorporate acts of aggres-
sion and are highly correlated to aggression and antiso-
cial lifestyles, like ODD, CD, and ASPD, were included. 
Articles referring to associations between genetic data 
and other (neuro)psychiatric disorders as main outcome 
(e.g. psychosis, borderline personality disorders, schizo-
phrenia, bipolar disorder, anxiety, major depression, intel-
lectual disability, Alzheimer’s disease, autism, ADHD, 
and addictions) were excluded. This increased the prob-
ability that the genetic profile that we examined was not 
confounded due to high comorbidity of aggression with 
other psychiatric disorders. Articles referring to aggres-
sion from the perspective of victimization and bullying 
were excluded. The publications were reviewed inde-
pendently by two authors (V.V.O and P.J.R.), and when in 
doubt other coauthors were consulted until consensus on 
inclusion was reached.
Selection procedure and analyses
The search on review/meta-analyses resulted in 1713 
records (Fig.  1). Duplicate entries were removed (N = 
27). Next, 1660 records were excluded based on screen-
ing the titles and abstracts. In total, 26 potentially rel-
evant reviews were retrieved for a full-text screening. 
Studies that did not fulfil or only partially fulfilled our 
criteria were excluded from the analysis (N = 12), lead-
ing to the inclusion of 14 articles. Four additional reviews 
were added through the automated selection, leading to a 
total of 18 articles – 13 targeted and 5 systematic reviews. 
These were organized into the following categories: 
review type (targeted or systematic), definition of aggres-
sion, type of reviewed studies (heritability, candidate 
gene, GWAS), population (children, adolescents, adults), 
quantity and period of the publications included in the 
reviews (parameters are made on the basis of reference 
lists with inclusion of publications on the aggression-re-
lated traits), described genes and main conclusions.
The search for GWASs on aggression resulted in 356 
records. A total of 331 were excluded based on screen-
ing of the titles and abstracts. This led to the retrieval 
of 25 potentially relevant studies for full-text screening. 
Studies that did not fulfil or only partially fulfilled our 
criteria were excluded (N = 8), leading to the inclusion 
of 17 GWAS articles. Three additional studies were 
selected from the automated selection, including one 
SNP-heritability and two linkage studies. The studies 
were analysed by phenotype, sample characteristics, 
SNPs, or genetic variants associated with aggression-re-
lated traits at P < 1E−05, genetic variants position in genes 
and chromosomes.
Several GWAS articles report findings on multiple (strat-
ified) GWASs. Tielbeek et al. (2017) adjusted for the 
fact that they performed three genome-wide association 
meta-analyses (GWAMA) by setting the genome-wide 
significance threshold at P = 1.67E−08, whereas others 
did not apply such a correction. This threshold might be 
overly conservative as the GWAMAs are stratified, which 
makes the P-values nonindependent across GWAMA. 
Therefore, we maintained a significance threshold of 
P = 5.0E−08 for all studies, and denote any SNP with a 
P-value below this threshold as genome-wide significant. 
While the traditional threshold might be too lenient in 
this context, we note that, when discussing GWASs, the 
P-value of a SNP in any given study is of less relevance 
than replication across GWASs.
Automated titles and abstracts screening
In parallel with the manual selection of titles and 
abstracts, another selection was made with the use of 
an automated selection tool ‘Automated Systematic 
Review’ (ASR) – software hosted at https://github.com 
(Automated systematic reviews by using Deep Learning 
and Active Learning, 2019). This software allows for 
Table 1 Inclusion and exclusion criteria for the systematic review
Selection criteria Inclusion criteria Exclusion criteria
Language English Non-English
Population Human studies (all ages) Animal studies
Use of term ‘aggression’ Psychological/psychiatric Disease characteristics (e.g. aggressive cancer, aggressive form of somatic diseases etc)
  Victimization, victims of bullying
Psychiatric disorders ODD, CD, ASPD Other neuropsychiatric and psychiatric disorders (e.g. psychosis, anxiety, etc)
Discussion of genes At least two genes associated with aggressiona No genetic methods and information on genes associated with aggression
ASPD, antisocial personality disorder; CD, conduct disorders; ODD, oppositional defiant disorder.
aThis was done to exclude reviews focussing on a single candidate gene.
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automated in- and exclusion of articles for systematic 
reviews based on the titles and abstracts of articles. This 
enabled a comparison between ‘traditional’ manual selec-
tion and the automated screening on performance char-
acteristics (e.g. time spent on selection and false-negative 
results). Furthermore, an additional selection was per-
formed with the ASR on a large dataset of references to 
retrieve any new additional articles to our review, which 
would have been missed in the traditional search strat-
egy (see Supplement S3, Supplemental digital content 3, 
http://links.lww.com/PG/A225).
We trained a model using ASR. To do so, the model 
requires a training set based on expert knowledge, con-
sisting of articles that are either labelled relevant or non-
relevant (labels 1 = included; 0 = not) (see Supplement 
S3: Figure S3.1, Supplemental digital content 3, http://
links.lww.com/PG/A225). To study the operating charac-
teristics of the ASR, we used a dataset (N = 2955) consist-
ing of relevant and nonrelevant articles on the genetics of 
human aggression, as labelled by researchers. From this 
labelled dataset of N = 2 955  500 records were repeatedly 
drawn at random as training sets. The number of rele-
vant records in the training sets varied between 10 and 
80 (e.g. 10 relevant records vs. 490 nonrelevant records), 
in increments of 10. These sets were used to train mod-
els to include relevant records and exclude nonrelevant 
records. For each model, we computed receiver operating 
characteristic parameters that were then used to select 
the optimal model (see Supplement S1: Table S3.1, 
Figure S3.2, Supplemental digital content 1, http://links.
lww.com/PG/A223). We selected the model that returned 
the lowest false-positive rate (FPR) while allowing for 
a maximum false-negative rate of FNR = 0.03 at most. 
Note that FNR = 0.03 corresponds with a true positive 
rate of TPR = 0.97.
We applied the optimal model to predict classification 
in different searches: (1) reviews of genetics of human 
aggression (1713 records); (2) GWASs on human aggres-
sion (356 records); (3) searches 1 and 2 combined (2069 
records) to analyse parameters of automated selection in 
comparison to manual selection.
Training sets were provided to the ASR for the reviews 
on aggression [26 relevant records out of 1713 (1.5%)] and 
the GWASs on aggression [25 relevant records out of 356 
(7.0%)] (see Supplement S3: Table S3.2, Supplemental 
digital content 3, http://links.lww.com/PG/A225). The 
automated selection predicted 1018 records out of 1713 
(59.4%) as relevant for reviews (including all prelabelled 
positives: TPR = 1.0; FPR = 0.59) and 243 records out 
of 356 (68.3%) for GWAS (including 24 prelabelled pos-
itives: TPR = 0.96; FPR = 0.66). Automated selection 
predicted 1261 records out of 2069 (60.9%) as important 
(including 50 prelabelled positives: TPR = 0.98; FPR = 
0.60). The workload for manual selection was ~60 hours. 
This means that for the applied model and these set(s), 
the reduction in workload is expected to be ~23.5 hours. 
By allowing for a higher FNR in model selection, the 
workload could be reduced even further, although at the 
expense of missing more true positives.
Our automated selection repeated the traditional man-
ual search with inclusion rates [100% for reviews (58.8% 
false positives), 96.0% for GWASs (66.2% false positives), 
98.4% for reviews and GWASs combined (60.0% false 
Fig. 1
Flow diagram of literature selection.
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positives)], 0 cases were false negatives for reviews, 1 case 
for GWASs, and 1 case for reviews and GWASs combined.
A new search on ‘human aggression genes’ was per-
formed in the same databases without additional search 
terms and time limitation (14 400 records) to detect new 
contributions to the systematic review, resulting in 55.8% 
included records. Exclusion of duplicate records resulted 
in 6469 records. From these, four reviews were added 
to the overview of reviews on aggression, and one SNP-
heritability and two linkage studies were added to the 
GWASs review as additional information for the inter-
pretation of GWAS findings. These seven studies were 
detected only by the ASR approach and did not appear in 
the traditional approach.
Results
We included 18 reviews on the genetics of human aggres-
sion in our analyses, each covering different periods and 
including varying numbers of studies (Table  2). The 
reviews cover more than 2000 studies on aggression.
What is considered to be aggression?
Reviews indicate that the phenotypic definitions of 
aggression vary considerably, and heterogeneity of the 
phenotypic definition is mentioned as a major hurdle 
in aggression research by multiple articles. Definitions 
of aggression, as well as the focal points of reviews, 
range from broadly defined externalizing and ASBs (see 
Supplement S1, Supplemental digital content 1, http://
links.lww.com/PG/A223), which also include potentially 
nonaggressive behaviours like rule-breaking behaviour 
(Fernandez-Castillo and Cormand, 2016), to a narrow 
focus on chronic physical aggression (Tremblay et al., 
2018). Other reviews and studies focus more explicitly 
on psychiatric classifications like ODD, CD, and ASPD, 
which encompass aggressive acts and are correlated 
to ASB (Veroude et al., 2016; Raine, 2019). One review 
incorporated the analysis of genetics of aggression in sui-
cidal behaviour (Baud, 2005). Classifications, which are 
useful in clinical practice, tend to consist of constella-
tions of heterogeneous ASBs (e.g. ‘often initiates physical 
fights’ vs. ‘is often truant from school’) and personality 
characteristics (e.g. ‘having difficulty sustaining long-
term relationships’ vs. ‘lacks concern, regret, or remorse 
about other people’s distress’ (American Psychiatric 
Association, 2013)).
Several reviews proposed a focus on more homogeneous or 
dimensional constructs of aggression (Fernandez-Castillo 
and Cormand, 2016; Tremblay et al., 2018). A dimensional 
construct is in line with the conceptualization that patho-
logical aggression is situated on the extreme ends of a 
normal distribution (Veroude et al., 2016). Some authors 
see a risk in the dimensional approach and note that find-
ings might become predominantly driven by variations 
within normal, adaptive levels of aggression (Ferguson, 
2010). However, if pathological levels of aggression are 
indeed the extreme end of a continuous phenotype, the 
same genetic and environmental factors should apply to 
both the normal range and extremes of the distribution.
In the end, concerns regarding heterogeneity and the 
impact of different phenotype definitions are empiri-
cal questions, which are currently also being asked in 
other GWASs of psychiatric disorders such as depres-
sion (Cai et al., 2019). Such questions can be resolved, 
once well-powered GWASs are available, by estimation 
of genetic correlations among different phenotype defi-
nitions of aggression and can also be addressed through 
genetic modelling of twin and family data. For example, 
Hendriks et al. (2019, submitted) analysed twin data col-
lected by multiple instruments, commonly employed to 
measure aggression in children. While phenotypic corre-
lations between different aggression scales could be low, 
a genetic multivariate analysis of these data showed high 
genetic correlations among different instruments. Such 
observations mean that different instrument tap into the 
same genetic liability and could be analysed simultane-
ously in GWAS.
Reviews that propose some sort of differentiation among 
aggressive behaviours often return to a distinction 
between reactive and proactive aggression. Reactive 
aggression is commonly described as impulsive and 
defensive, while proactive aggression is considered pred-
atory and premeditated. Both types of aggression may 
involve similar biological systems. The aminergic systems 
(e.g. serotonergic and dopaminergic) have been proposed 
as likely to regulate both forms of aggression (Waltes et 
al., 2016). Interestingly, Runions and colleagues (2019) 
argue that researchers studying reactive and proactive 
forms of aggression have conflated motivation (aversive 
vs. appetitive) and implementation (impulsive vs. pre-
meditated) and propose that predatory aggression can 
also be impulsive in nature, defined as recreation instead 
of rage, while reactive aggression could also be delivered 
after a longer period of time, referring to reward instead 
of revenge.
The developmental aspect of aggression is a major theme 
in reviews (Moffitt, 2005; Tuvblad and Baker, 2011; 
Provencal et al., 2015; Veroude et al., 2016; Waltes et al., 
2016; Davydova et al., 2018). Age of onset is often men-
tioned as an important differentiating factor for subtypes 
of ASB, with aggression usually already present in early 
childhood, while rule-breaking behaviour and delin-
quency usually develop during adolescence. Tremblay 
(2010) proposes a developmental framework of aggres-
sion among a covert/overt axis and a second destructive/
nondestructive axis as the most viable constructs to sub-
type disruptive behaviour (aggression, opposition-defi-
ance, rule breaking, and stealing-vandalism). Children 
who display destructive and overt disruptive behaviours, 
especially those exhibiting chronic physical aggression, 
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experience more risk factors early in life, engage in 
aggression from a young age, and have a more persistent 
developmental course of aggression and ASB. A differen-
tiation on age of onset is considered especially relevant in 
reviews, which include epigenetics. Epigenetic changes 
may be triggered by early life adversity (Provencal et al., 
2015; Manchia and Fanos, 2017; Tremblay et al., 2018; 
Curry, 2019), although variation in epigenetic marks 
can also reflect influences of DNA polymorphisms (van 
Dongen et al., 2016).
In research, aggressive behaviour often is measured 
by questionnaires, such as the Achenbach System 
of Empirically Based Assessment scales (ASEBA; 
Achenbach et al., 2017), the Strengths and Difficulties 
Questionnaire (SDQ; Goodman et al., 2010), or the Buss 
Durkee Hostility Inventory (BDHI; Buss and Durkee, 
1957). Aggression scales in such instruments may include 
items which reflect behaviour that is related to aggres-
sion, but would not be considered aggression based 
on item content. For example, the ASEBA Aggressive 
Behaviour scale for children contains items like ‘Argues a 
lot’ or ‘Gets in many fights’, but also ‘Unusually loud’ or 
‘Suspicious’. Measures can also derive from observational 
studies, especially in younger children, and some experi-
mental paradigms are available to measure aggression in 
across wider age ranges. Such experiments can, however, 
not cover the full spectrum of aggressive behaviour and, 
perhaps even more critically, cannot be applied in epide-
miological samples.
There is a divergence between measurement of aggres-
sion in research projects compared to how (pathological) 
aggression is defined in clinical practice. Questionnaires 
are used as tools by clinicians, but the presence of these 
behaviours is mostly determined by interviews with the 
patient, and others who know the person (e.g. parents 
and teachers), by observation, and by the patient’s (crimi-
nal) records. Psychiatric disorders that include aggressive 
behaviours or disorders, which are correlated to aggres-
sive and antisocial lifestyles, are dependent on classifica-
tion systems like the Diagnostic and Statistical Manual 
of Mental Disorders (DSM) and the International 
Classification of Diseases (ICD). In these classifications, 
a dichotomy is applied in which a disorder is either pres-
ent or absent, largely ignoring the dimensional nature 
of human behaviour. In genetic studies, a focus on the 
dichotomy rather than on continuous variation may lead 
to a loss of statistical power (van der Sluis et al., 2013).
Another important question, especially in clinical set-
tings, is when aggression becomes pathological. Some 
aggressive behaviours are clearly defined as pathological, 
like aggressive behaviours that define CD (e.g., ‘Has used 
a weapon that can cause serious physical harm to others) 
or ASPD (e.g., ‘Irritability and aggressiveness, as indi-
cated by repeated physical fights or assaults’). In contrast, 
other aggressive behaviours are less clearly considered 
pathological, because they occur to some extent in all 
individuals, like anger or hostility. This even is the case 
for some aggressive behaviours, which are part of disrup-
tive behaviour disorders (e.g., ODD: often argues with 
authority figures). For aggression to be pathological, it is 
essential that aggressive behaviours cause clinically sig-
nificant impairment in social, academic, or occupational 
functioning.
Approaches in genetics of aggression studies and the 
current status quo
There are several designs to study the genetic aetiology 
of aggression, with the two major ones being genetic 
epidemiological/behavioural genetic approaches on the 
one hand and molecular genetic approaches on the other 
(Fig. 2). Behavioural genetic studies have a long and suc-
cessful history (Loehlin, 2009). More recently, molecular 
genetic studies have seen enormous breakthroughs with 
the development of techniques like GWASs (Visscher et 
al., 2017).
Behavioural genetic approaches
Numerous studies focused on explaining the aetiology of 
aggression and ASB through family, twin, and adoption 
studies, which can disentangle genetic and environmen-
tal influences. Twin models enable researchers to divide 
the variance for a trait, or the liability to a disorder, into 
genetic and nongenetic components. The genetic var-
iance component often is defined as the additive (A) 
effects of many genes. Environmental variance compo-
nents consist of environmental influences common to 
siblings from the same family (C), creating resemblance 
of family members through environment rather than 
through genetics, and a unique or nonshared environ-
mental component (E). Unique environmental influ-
ences affect family members in different ways (Boomsma 
et al., 2002). Unsystematic influences such as measure-
ment error also are included in the E component, unless 
explicitly modelled. In general, reviews indicate that 
additive genetic factors explain around 50% of the var-
iability of aggressive behaviour (Craig and Halton, 2009; 
Rhee and Waldman, 2011; Tuvblad and Baker, 2011; 
Fernandez-Castillo and Cormand, 2016). The estimate 
varies around 50% across studies, with some reviews 
reporting somewhat higher heritability estimates (65%) 
and others giving estimates for aggression and ASB that 
vary more [e.g. 38–88% (Veroude et al., 2016); 28–78% 
(Tuvblad and Baker, 2011)]. Physical aggression seems 
to show larger heritability estimates (65%) than reac-
tive (20–43%) and proactive aggression (32–48%), while 
rule-breaking behaviour, which is often aggregated with 
aggression indices, also shows a heritability around 50% 
(Waltes et al., 2016; Gard et al., 2018). Heritability esti-
mates of aggressive behaviour were higher in children 
with stable callous unemotional traits (81%) compared to 
children low in callous unemotional traits (30%) (Gard et 
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al., 2018). This suggests a larger influence of genes on 
children with more severe aggressive tendencies (Gard 
et al., 2018). Contributions of shared environment are 
relatively small and decrease with age, with the vast 
majority of adult studies not reporting any shared envi-
ronmental influences (Tuvblad and Baker, 2011; Veroude 
et al., 2016; Waltes et al., 2016). Thus, research in behav-
iour genetics clearly indicates that there is a substantial 
genetic component to aggressive behaviour in humans. 
In longitudinal studies, heritability estimates of aggres-
sion and ASB increase somewhat from childhood through 
adulthood (Tuvblad and Baker, 2011; Veroude et al., 2016; 
Waltes et al., 2016). Genetic factors also contribute to the 
stability of aggressive behaviour during preschool and 
school age, and puberty (Porsch et al., 2016; Waltes et al., 
2016). Measurement instrument, and also rater, seem to 
influence heritability estimates, with heritability based 
on parent-report and teacher-report estimated as higher 
than those based on self-report and observational studies. 
Studies based on self-report tend not to find any shared 
environmental influences (Tuvblad and Baker, 2011), 
but such studies are not available for younger children. 
Unlike parent or teacher reports, observational studies 
more often give an assessment of aggression at one par-
ticular moment in time only. Parent- and teacher-reports 
tend to provide phenotype information that is more aver-
aged over longer periods of time and are similar in terms 
of heritability estimates. Parent-report leads to higher 
estimates of shared environmental influences than teach-
er-report, when parental characteristics that influence rat-
ings of multiple children (e.g. twins or siblings) are not 
taken into account. When twins have different teachers, 
similarities between them tend to decrease. This may 
reflect actual differences in aggressive behaviour with 
different teachers and/or different settings, but may also 
reflect teacher characteristics that influence assessments 
of multiple children.
In summary, heritability is estimated consistently around 
50%, with some variation that may be due to different 
conceptualization of aggressive and ASBs, with more 
severe types of aggression showing higher heritability.
Heritability estimates of aggression and ASB may differ 
between environments suggesting an interaction between 
genes and environment (GxE). Proposed putative envi-
ronmental moderators are familial adversity (e.g. mal-
treatment and parental delinquency), social disadvantage 
(e.g., poverty and bad neighbourhoods), violent media 
exposure, and alcohol use. Tuvblad and Baker (2011) 
argue that, compared to genetic factors, environmental 
influences are relatively more pronounced for ASBs in 
the presence of high environmental risk and disadvan-
taged environments. Conversely, genetic influences will 
be more pronounced when environmental risk factors are 
absent or less prominent. In one study, the moderating 
effects of neighbourhood seemed to be specific to the 
heritability of nonaggressive ASB, while heritability esti-
mates of aggressive ASB were not influenced by neigh-
bourhood disadvantage (Burt et al., 2016). Such findings 
underscore the differential influence of environmental 
adversity on certain types of ASB, with aggressive behav-
iour showing less sensitivity to environmental influences 
than other types of ASB. Later reviews, however, indicate 
mixed findings. Some reported an increase in genetic var-
iance in the presence of environmental risk. To illustrate, 
when young children were subjected to high levels of 
maternal disengagement, genetic factors explained more 
variance in later conduct problems (Boutwell et al., 2012; 
Waltes et al., 2016). An increase in heritability of external-
izing disorders was also found when young adults were 
Fig. 2
Interplay of genetic, epigenetic, and environmental factors in behaviour and genetic studies of aggression.
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exposed to a combination of risk factors [e.g. antisocial 
or lack of prosocial peers and relationship problems with 
parents (Hicks et al., 2009; Veroude et al., 2016)].
Depending on the type of aggression, mean levels of 
aggression often are higher in males than in females. 
Differences in heritability estimates, however, between 
males and females are modest or absent. According to 
Tuvblad and Baker (2011), heritability did not differ sig-
nificantly between genders across different twin studies, 
either quantitatively or qualitatively [see also (Vink et al., 
2012)]. These studies mainly included mother-reports 
of childhood aggression and heritability estimates were 
higher in males than in females when self-report data 
were analysed (Waltes et al., 2016). It has been suggested 
that gender differences in heritability become more pro-
nounced from adolescence, which could be indicative 
of the ‘Young Male Syndrome’, in which the onset of 
puberty and increasing levels of testosterone are related to 
increases in aggression in 12- to 25-year-old males (Craig 
and Halton, 2009). This would also suggest a possible role 
of genes related to androgen synthesis and function in the 
development of aggression from puberty onwards.
In summary, twin studies highlight the importance of 
genetic influences, with estimates of the heritability of 
aggression and ASB often reported to be around 50% 
(Moffitt, 2005), without much evidence for sex differ-
ences in heritability estimates. Such significant heritabil-
ity is a first requirement for initiating studies that aim to 
find molecular signatures in the DNA sequence that are 
associated or causally related to the phenotype.
Integrating data on genetics of aggression from 
molecular genetic studies
Genetic linkage and candidate gene studies: Molecular genetic 
studies include genetic linkage and association studies, 
either genome-wide or with a focus on a limited number 
of candidate genes or candidate regions. In linkage stud-
ies, DNA markers are assessed in related individuals to 
investigate the inheritance of markers with known chro-
mosomal locations together with aggression in pedigrees. 
Sometimes candidate regions to be investigated are sug-
gested from studies in other species. With the arrival of 
large-scale association studies, linkage studies, which 
require family-based designs, have become less common, 
but early studies have suggested regions on three chro-
mosomes that could be associated with aggression. Dick 
et al. (2004) analysed retrospectively reported childhood 
CD in an adult sample from COGA (Collaborative Study 
on the Genetics of Alcoholism). Regions on chromosomes 
19 and 2 may contain genes associated with risk of CD. 
The same region on chromosome 2 has been linked do 
alcohol dependence in this sample. Criado et al. (2012) in 
a linkage study of cortical even-related oscillations asso-
ciated with ASPD and CD suggested that chromosome 1 
may contain a genetic locus for ASPD/CD.
Genetic association studies initially were candidate gene 
studies. These require a priori knowledge of or hypoth-
eses about which genes are implicated in the aetiology 
of the trait of interest. For aggression, associations were 
considered for genes from the serotoninergic [5-HTTLPR 
(5-hydroxytryptamine (serotonin) receptors), SLC6A4 
(solute carrier family 6 member 4)], dopaminergic [dopa-
mine receptors genes DRD4, DRD2, DRD5, and SLC6A3 
(solute carrier family 6 member 3)] and GABAergic sys-
tems [e.g. genes that code GABA (gamma-aminobutyric 
acid) receptors, like GABRA2 (gamma-aminobutyric 
acid type A receptor alpha2 subunit)], as well as genes 
related to catecholamine catabolism [MAOA (monoam-
ine oxidase A), COMT (catechol-O-methyltransferase)] 
(Provencal et al., 2015; Fernandez-Castillo and Cormand, 
2016; Veroude et al., 2016; Davydova et al., 2018; Gard 
et al., 2018). Other studies focused on associations with 
the genes involved in stress response pathways (Craig 
and Halton, 2009; Waltes et al., 2016); hormone regula-
tion [e.g., AVPR1A (argenine vasopressin receptor 1A)] 
(Fernandez-Castillo and Cormand, 2016; Veroude et 
al., 2016; Waltes et al., 2016; Salvatore and Dick, 2018); 
hypoglycaemia and insulin secretion (Craig and Halton, 
2009); and neuronal transcripts and brain expression pat-
terns (Craig and Halton, 2009; Anholt and Mackay, 2012; 
Waltes, Chiocchetti and Freitag, 2016; Gard et al., 2018). 
Candidate gene studies have been criticised (e.g. Duncan 
and Keller, 2011), since it became clear that findings for 
candidate genes are often not replicated in well-powered 
GWASs (e.g. Bosker et al., 2011; Luo et al., 2016). It is 
likely that this also extends to studies of aggression, but 
the status of the candidate genes for aggression must 
await well-powered GWASs.
Many reviews agree that aggression is a polygenic trait 
influenced by many genes and that each explains a small 
proportion of the phenotypic differences. However, there 
may be an overlap between genes of large effect underly-
ing monogenic disorders and those affecting continuous 
variability of related quantitative traits. Extending the 
idea of a shared genetic basis between Mendelian disor-
ders and polygenic traits, one alternative approach based 
on the search for genes for aggression in studies of rare, 
functional genetic variants associated with aggression 
phenotypes catalogued in Online Mendelian Inheritance 
in Man [OMIM; (Zhang-James and Faraone, 2016)]. Most 
of these genes had not been implicated in human aggres-
sion before, but the most significantly enriched pathways 
(e.g. serotonin and dopamine signalling) had been pre-
viously implicated in aggression. Among these genes, 
only two were previously related to aggression [MAOA, 
GRIA3 (glutamate ionotropic receptor AMPS type sub-
unit 3)]. New associations were found with genes [e.g. 
CAMTA1 (calmodulin binding transcription activator 1), 
APBB2 (amyloid beta precursor protein binding fam-
ily B member 2), DISC1 (DISC1 scaffold protein), and 
others], which implicated in  cell-to-cell signalling and 
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interaction, nervous system development and function, 
and behaviour. The novel genes and pathways identified 
in this study suggested additional mechanisms underly-
ing aggression.
Genome-wide association studies: GWASs investigate mil-
lions of SNPs, under a continuous or dichotomous, case/
control model. The result is a list that, for every variant, 
indicates the expected increase in a trait (continuous) or 
genetic liability (dichotomous) for every copy of an effect 
allele. Due to the large number of tests, the genome-wide 
significance level is set at P = 5.0E−08 (Sham and Purcell, 
2014), to properly control for the type I error rate. This 
adjusted threshold already considers the fact that neigh-
bouring SNPs are not inherited independently from one 
another. However, the nonindependent inheritance of 
SNPs indicates that association tests between noncausal 
SNPs and the trait of interest contain a part of the poly-
genic signal (Bulik-Sullivan et al., 2015). As such, even 
when only a limited number of SNPs reach this stringent 
significance level, there is signal in the other association 
tests. The weighted effects of all the genetic variants 
involved in aggression could produce a polygenic risk 
score with a certain predictive value (Beaver et al., 2018).
Many reviews discussed a whole-genome approach to 
understanding aggression, but only three have done so in 
a systematic manner (Fernandez-Castillo and Cormand, 
2016; Veroude et al., 2016; Waltes et al., 2016). We will 
summarize findings for genes harbouring, or in proxim-
ity to, variants that reached genome-wide (P ≤ 5.0E−08) 
or nominal (P ≤ 1.0E−05) significance levels in all GWAS 
of aggression phenotypes to date. These include aggres-
sion-related phenotypes, i.e. anger, hostility dimensions, 
aggressive behaviour, physical aggression, ASB, violent 
offending, CD, ODD, and ASPD.
To provide a complete picture of the GWAS literature 
available, we chose to include phenotypes, which clearly 
include aggression, but are sometimes conflated with other 
ASBs (e.g. rule breaking) or personality characteristics 
(e.g. being suspiciousness and being loud). These pheno-
types can be found in Supplement S4, Supplemental dig-
ital content 4, http://links.lww.com/PG/A226. Most GWASs 
on aggression were performed in child and adolescent 
samples of European ancestry, in which aggression was 
assessed using rating scales (Table 3).
GWAS studies have mainly resulted in nominal associ-
ations between genetic variants and aggression-related 
traits and disorders. Collectively, these studies reported 
10 genome-wide significant findings (Dick et al., 2011; 
Rautiainen et al., 2016; Tielbeek et al., 2017; Montalvo-
Ortiz et al., 2018). Five of these variants are located inside 
or close to four genes: LINC00951 (long intergenic nonpro-
tein coding RNA 951) (Rautiainen et al., 2016), C1QTNF7 
(C1q tumor necrosis factor-related protein 7) (Dick et al., 
2011), PSMD1 (proteasome 26S subunit, non-ATPase 
1), and HTR2B (5-hydroxytryptamine receptor 2B) 
(Montalvo-Ortiz et al., 2018). Lastly, the five remaining 
significant SNPs are located on chromosomes 11 (Dick 
et al., 2011; Tielbeek et al., 2017), 13 (Dick et al., 2011), 1, 
and X (Tielbeek et al., 2017).
In a mixed sample of subjects from European and African-
American ancestry, three SNPs inside C1QTNF7 were 
significantly associated with CD symptoms in adults with 
substance dependence (Dick et al., 2011). When the sam-
ple was split on the basis of ancestry, no SNPs reached 
suggestive levels in the European-American sample. In 
the African-American sample, one out of the three SNPs 
reached suggestive levels (minimum P = 4.35E−06), along 
with two additional suggestive findings (minimum P = 
2.67E−07). C1QTNF7 is less expressed in the brain, com-
pared to such tissues as endometrium, gall bladder, lungs, 
ovaries and 18 other tissues, and has a potential role in 
maintaining energy balance (Kaye et al., 2017).
In a study focusing on ASPD in Finnish criminal offend-
ers, Rautiainen and colleagues (2016) found one hit 
(rs4714329, P = 1.6E−09) in the cross-sex meta-analysis. 
This variant is in proximity to LINC00951 (long intergenic 
nonprotein coding RNA 951). The same SNPs returned 
suggestive associations in the male-specific GWAMA of 
ASPD (P = 1.38E−07). The signal from these variants was 
specific for ASPD, and did not cover a broader range of 
criminal behaviour. Montalvo-Ortiz and colleagues (2018) 
found that SNPs located in the HTR2B (P = 2.16e−08) and 
PSMD1 (P = 1.79e−08) genes were significantly associated 
with cannabis-related physical aggression in African-
Americans, but these SNPs did not reach even suggestive 
significance in European-Americans. Cannabis use has 
been associated with greater impulsive decision-mak-
ing and increased aggressive behaviour. Notably this is 
the only GWAS study which focused purely on physical 
aggression.
Anney and colleagues (2008) listed 54 SNPs nominally 
associated with conduct problems. These SNPs tagged 
41 genes, three of which are with known functions and 
are involved in the regulation of dopamine receptor D2 
signalling [PAWR (proapoptotic WT1 regulator)], synap-
tic plasticity [KIRREL3 (kirre like nephrin family adhe-
sion molecule 3)], and neuronal development [RBFOX1 
(ral guanine nucleotide dissociation stimulator like 1)]. 
Sonuga-Barke and colleagues (2008) analysed interactions 
between CD symptoms and maternal warmth. Nominal 
effects were found for SNPs located in genes involved 
in brain maturation, neurotransmission, neuronal devel-
opment, and regeneration. Viding and colleagues (2010) 
examined teacher-reported conduct problems in children 
and found no suggestive SNPs (minimum P = 4.6E−05).
For adult ASB (Tielbeek et al., 2012), the strongest sig-
nal was for a SNP (rs346425; P = 2.51E−07) located on 
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chromosome 5. Salvatore and colleagues (2015) in an 
adult ASB sample observed the strongest association for 
rs4728702 (P = 5.77e−07), located in ABCB1 (ATP binding 
cassette subfamily B member 1) on chromosome 7 that 
may confer general risk across a wide range of external-
izing behaviours. Enrichment analyses further indicated 
involvement of immune-related pathways. Two GWASs 
compared cohorts of Finnish violent offenders to the 
general population (Tiihonen et al., 2015; Rautiainen 
et al., 2016), and obtained association signals at genes 
involved in neuronal development (Tiihonen et al., 2015) 
and adaptive immunity (Rautiainen et al., 2016).
Aebi and colleagues (2016) hypothesized that BCL2L1 
(BCL2 like 1) is likely associated with oppositional 
behaviour, because of its influence on presynaptic plas-
ticity through regulation of neurotransmitter release and 
retrieval of vesicles in neurons. Brevik and colleagues 
(2016) applying gene-based tests observed NTM (neuro-
trimin) as the top gene, which is differentially expressed 
in aggression-related structures of the amygdala and the 
prefrontal cortex in early stages of brain development.
Merjonen and colleagues (2011) saw suggestive asso-
ciations for SNPs that lie inside genes involved in the 
maintenance of high frequency synaptic transmission 
at hippocampal synapses, and regulating synaptic acti-
vation [SHISA6 (shisa family member 6)]  in a Finnish 
population sample. Mick and colleagues (2011) found 
associations for SNPs that lie inside or close to multi-
ple genes, including LRRC7 (leucine-rich repeat con-
taining 7), involved in neuronal excitability and used 
as postsynaptic marker of hippocampal glutamatergic 
synapse integrity, and STIP1 (stress-induced phos-
phoprotein 1), involved in astrocyte differentiation and 
highly expressed in the brain. A second GWAS by Mick 
and colleagues (2014) observed a nominal association of 
proneness to anger with the gene, involved in calcium 
influx and release in the postsynaptic density, and in 
long-term potentiation [FYN (FYN proto-oncogene, Src 
family tyrosine kinase)]. McGue et al. (2013) reported 
four SNPs associated with behavioural disinhibition 
including symptoms of CD and aggression, one of which 
(rs1368882; P = 1.90E−06) was located inside the GLIS1 
(GLIS family zinc finger 1) gene responsible for a tran-
scription factor that is involved in regulating the expres-
sion of numerous genes.
Recently, two larger studies attempted to identify genes 
associated with aggression or ASB by increasing power 
through the inclusion of multiple cohorts. Pappa and col-
leagues (2016) collected a sample of 18 988 children 3–15 
years for meta-analysis and reported a near genome-wide 
significant locus on chromosome 2p12 (P = 5.3E−08). This 
locus is in proximity to two genes: LRRTM4 (leucine-rich 
repeat transmembrane neuronal 4), which regulates 
excitatory synapse development, and SNAR-H (small 
NF90 (ILF3) associated RNA H), which is implicated 
in the transcription process and is expressed in neurons. 
They found 19 genes nominally related to aggression 
from gene-based tests, which include LRRTM4, PDSS2 
(decaprenyl diphosphate synthase subunit 2), TRIM27 
(tripartite motif containing 27), MRC1 (mannose recep-
tor C-type 1), MECOM (MDS1 and EVI1 complex locus), 
and CASC17 (cancer susceptibility 17).
Another larger study by Tielbeek and colleagues (2017) 
focused on the broader ASB phenotype in 16 400 individ-
uals. The overall GWAMA found no hits, but sex-strati-
fied GWAMAs returned three genome-wide significantly 
associated SNPs (minimum P = 1.95E−08), but failed 
to identify significant genes. This suggested that there 
might be sex-specific genetic effects on ASB and focus-
ing on a more specific phenotype could improve chances 
of findings significant results.
Thus, nominal genome-wide associations (P < 1E−05) 
have been found in genes involved in a wide variety of 
biological systems: the immune system, the endocrine 
system, pathways involved in neuronal development and 
differentiation and synaptic plasticity. These findings 
have not been replicated across GWASs, but some studies 
reported the same genes independently: NTM (Tiihonen 
et al., 2015; Brevik et al., 2016) and RBFOX1(A2BP1) 
(Anney et al., 2008; Sonuga-Barke et al., 2008).
In summary, the 17 GWASs in our review show that 
genome-wide significant and/or suggestive associations 
between aggression-related traits and SNPs are found 
on all chromosomes (range: 1–63; see Supplement S5-6, 
Supplemental digital content 5, http://links.lww.com/PG/
A227; Supplemental digital content 6, http://links.lww.
com/PG/A228). As shown in Fig. 3, nearly 55% of sugges-
tive associations were found on chromosomes 1, 2, 5, 6, 
7, 9, 10, and 11, with the majority of suggestive SNPs on 
chromosome 7 reported in the sample of African ancestry 
(Montalvo-Ortiz et al., 2018). The genome-wide signifi-
cant associations are located on chromosomes 1, 2, 4, 6, 
11, 13, and X.
Discussion
Aggression has a considerable genetic component, as 
indicated by decades of behaviour genetics research. 
However, no genomic variants have (yet) been identi-
fied. In our review covering GWASs on human aggres-
sion, only 4 out of 17 studies reported genome-wide 
significant hits in primary or replication samples (Dick 
et al., 2011; Rautiainen et al., 2016; Tielbeek et al., 2017; 
Montalvo-Ortiz et al., 2018). In the reviews on aggression 
and GWASs, several explanations are offered for the dis-
crepancy between heritability estimates in behavioural 
and molecular genetic studies; for example, the heteroge-
neous, context-dependent, and developmental nature of 
aggression, but foremost, small sample sizes. Fortunately, 
these limitations can be remedied and provide future 
directions for research.
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Most of the reviews covered mention the often cited 
heritability estimates of 50% for aggression by Miles and 
Carey (1997), and 41% for ASB by Rhee and Waldman 
(2002) and these estimates are confirmed in more recent 
empirical studies. Moderation, or any genotype × envi-
ronment effects seem small, and most pronounced for 
nonaggressive ASB (Burt et al., 2016).
How to address nonsignificant findings in GWAS studies 
on psychiatric problems is a pressing issue. Opinions are 
divided on what approach is most optimal to define phe-
notypes for GWAS analyses. Some believe that reduc-
tion of phenotypic heterogeneity could lead to more 
genome-wide significant findings (Anholt and Mackay, 
2012; CONVERGE consortium et al., 2015; Runions et 
al., 2019). This view is supported by the GWASs cov-
ered in this review that did find genome-wide significant 
hits. These relatively underpowered studies (Nrange = 
2185–6220 participants) focus on individuals with severe 
ASB and specific types of aggression: individuals with 
DSM-defined CD symptoms (Dick et al., 2011), canna-
bis-induced physical aggression (Montalvo-Ortiz et al., 
2018), and criminal offenders with ASPD (Rautiainen et 
al., 2016). Two studies were conducted in specific sam-
ples; exclusively male, with associations only in African-
American subgroup (Montalvo-Ortiz et al., 2018), and 
predominantly male (89% of cases) and ethnically homo-
geneous (Rautiainen et al., 2016).
In contrast, other researchers propose a broader approach, 
which includes more lenient phenotypes (Vassos, Collier 
and Fazel, 2014; Ormel et al., 2019). This lenient pheno-
typing approach has already achieved success in depres-
sion research; for example, although here the value of 
minimal versus broader phenotyping is debated as well 
(Cai et al., 2019). The two largest GWASs on aggression 
that were covered by this review used broad, lenient 
measures of childhood aggression (Pappa et al., 2016) and 
ASB (Tielbeek et al., 2017). Pappa and colleagues (2016) 
found no significant hits, but several promising loci on 
chromosomes 2, 3, 6, and 17 (minimum P = 5.3E−08). 
Tielbeek and colleagues (2017) reported three significant 
hits for the sex-stratified GWAMAs.
Early linkage studies on aggression indicated chro-
mosomes 1 (Criado et al., 2012), 2, and 19 (Dick et al., 
2004) as potential loci. GWAS findings in our review 
Fig. 3
Number of genetic variants associated with aggression-related traits at P ≤ 1E-05 on different chromosomes reported in the included genome-wide 
association studies (GWAS) studies. The x-axis shows chromosome number and length (in base pairs). N
studies
 = 17, N
variants
 = 817.
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confirm loci on chromosomes 1 and 2, which gave more 
associated variants and significant results. The X- and 
Y-chromosomes did not give evident results, even if 
one significant sign was reported in X-chromosome 
(Tielbeek et al., 2017).
To identify 80% of all causal SNPs, depending on 
the extent of SNP heritability, between 105 and 107 
(100  000–10  000  000) independent subjects would be 
required (Holland et al., 2019). This means that, with 
sample sizes l0 time less than the lower bound, current 
GWASs were clearly underpowered. At present, several 
initiatives are under way to collaborate in achieving larger 
sample sizes. One example of a large collaborative pro-
ject is the ACTION consortium (Aggression in Children: 
Unraveling gene-environment interplay to inform 
Treatment and InterventiON strategies: http://www.
action-euproject.eu/), which has brought together over 
30 cohorts with childhood data on aggression for GWAS, 
EWAS, and biomarker studies.
As mentioned, multiple reviews suggest that heteroge-
neity of aggression is a problem in research, with several 
reviews suggesting some kind of distinction between sub-
types, subgroups, or developmental stages. Standardized 
phenotypic and environmental assessments are proposed 
as a solution (Craig and Halton, 2009). Although this 
standardization of assessment could be an option, recent 
advances in multivariate modelling allow for exploration 
of other potential avenues (e.g. Baselmans et al. 2019). 
This approach is also discussed in the meta-analyses 
of Zhang-James and Faraone (2016), in which aggres-
sion might be considered a multidimensional trait con-
sisting of distinct, but related, constructs with shared 
aetiologies (Zhang-James and Faraone, 2016). In other 
words, although some individuals show different prob-
lem behaviours, including aggression, they all share a 
common genetic vulnerability. Taking a multivariate, 
approach would allow the inclusion of large cohorts with 
existing phenotypic (Bartels et al., 2018) and SNP data. 
However, the focus on ever broader phenotypes and big-
ger samples raises the question how to translate results 
into practice, to alleviate problems of individuals.
Future directions
We should recognize that the nature-nurture debate has 
moved on from the question whether aggressive behav-
iour is heritable to the discovery of the biological bases 
of aggression. This is currently achieved by investigating 
aggression’s relation to genes, SNPs, and relevant biolog-
ical pathways. It is expected that GWASs with larger or 
combined datasets will improve our understanding of the 
mechanisms of gene regulation of aggression. Individual 
GWASs on aggression and aggression-like traits are still 
limited in terms of explaining variation in the population, 
but ongoing GWASs and other efforts, e.g. in epigenetics 
and biomarker studies are likely provide insight into the 
aetiology of aggressive behaviour. Expansion of disease 
gene maps (Goh et al., 2007) by including aggression-re-
lated traits into, for example, OMIM datasets can help 
in future analyses of underlying cellular network-based 
relationships between genes and functional modules 
of aggressive behaviour, and future work should deter-
mine whether genes mediating aggression pathways are 
enriched in the polygenic background of disorders asso-
ciated with aggression.
Also, leveraging on genotype-tissue expression [GTEx; 
(eGTAxProject, 2017)] GWAS findings can be annotated 
with additional information and thereby identify biologi-
cally relevant systems. One particularly interesting source 
of biological annotation revolves expression quantitative 
trait loci (eQTL), i.e. SNPs that have been associated 
with gene expression levels. Once genome-wide hits are 
found, overlapping these with known eQTLs could iden-
tify genes that are of biological interest (Lowe et al., 2015; 
Gusev et al., 2016; Zhu et al., 2016).
Systematic reviews with automated functions
The workload on selection process of researchers in our 
systematic review was around 60 hours (screening and 
selecting relevant articles from list of 2069 records). By 
using automated procedures to screen for relevant litera-
ture for inclusion in systematic reviews, it was possible to 
save 39.1% (23.5 h) of reading/scanning time. The down-
side of automated methods is that relevant literature 
can be missed. On the contrary, even an expert reviewer 
might omit studies that the automated procedures 
include. Optimization of the expert reviewer is covered 
by education and training, whereas optimization of auto-
mated selection is under active development (Cohen et 
al., 2006; Khabsa et al., 2016; Borah et al., 2017). We opted 
for a recent approach that utilizes a machine learning 
algorithm to obtain a selection of articles that could be 
relevant for this systematic review.
Although the ASR tool we applied is quite new and is 
still under active development, we found that apply-
ing the machine learning approach as implemented in 
the software hosted at https://github.com (Automated 
systematic reviews by using Deep Learning and Active 
Learning, 2019) could be indeed of considerable aid to 
the researcher performing a systematic review solving 
problems of missed literature in screening phase due to 
human errors or excluded by searching algorithms.
For the benefit of further developments in automated 
selection approaches aiding the review process, we advise 
review authors to supply their search results as additional 
information to their work. These results can then serve 
for further refinement of literature search models. This 
would avoid double work across research groups, cre-
ate a comprehensive overview of aggression literature, 
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and increase our understanding of the genetic nature of 
human aggression.
Conclusion
Aggression in humans is a heritable trait, whose genetic 
basis largely remains to be uncovered. No sufficiently 
large GWASs have been carried out yet. With increases 
in sample size, we expect aggression to behave like 
other complex human traits for which GWAS has been 
successful. There are several ongoing efforts to achieve 
genome-significant GWAS findings – merging samples in 
consortia, replication strategies, searching for close phe-
notypes from other domains associated with aggression 
for sample extension, developing new approaches of par-
titioning genetic heterogeneity and sample stratification. 
Automated tools for systematic review, which are based 
on machine learning, could be used to optimize the inte-
gration of research findings from different studies.
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